Tuncay Goksel
Overview
Explore the profile of Tuncay Goksel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
2118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Omar A, Asadi M, Mert U, Muftuoglu C, Karakus H, Goksel T, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076874
Tumor-associated macrophages (TAMs) significantly influence tumor progression and patient responses to conventional chemotherapy. However, the interplay between anti-cancer drugs, immune responses in the tumor microenvironment, and their implications for cancer...
2.
Atalay-Sahar E, Yildiz-Ozturk E, Ozgur S, Aral A, Dayanc E, Goksel T, et al.
Expert Rev Mol Med
. 2025 Mar;
:1-29.
PMID: 40070355
No abstract available.
3.
Tetik Vardarli A, Karakus H, Korba K, Boluk B, Ozgur S, Gunduz C, et al.
Thorac Cancer
. 2025 Jan;
16(1):e15513.
PMID: 39810398
Background: Lung cancer continues to be the primary cause of cancer-related deaths globally, with the majority of cases identified at advanced stages. Genetic alterations, including mutations and gene fusions, are...
4.
Saglam-Metiner P, Yildiz-Ozturk E, Tetik-Vardarli A, Cicek C, Goksel O, Goksel T, et al.
Tissue Cell
. 2024 Feb;
87:102319.
PMID: 38359705
Reliable and effective models for recapitulation of host-pathogen interactions are imperative for the discovery of potential therapeutics. Ex vivo models can fulfill these requirements as the multicellular native environment in...
5.
Goksel T, Ozgur S, Tetik Vardarli A, Koc A, Karakus H, Ozdemir T, et al.
Front Oncol
. 2024 Feb;
13:1275525.
PMID: 38304031
Introduction: Lung cancer (LC) is a leading cause of cancer-related mortality worldwide. Approximately 80% of LC cases are of the non-small cell lung cancer (NSCLC) type, and approximately two-thirds of...
6.
Salivary Lipids of Patients with Non-Small Cell Lung Cancer Show Perturbation with Respect to Plasma
Hwang B, Seo J, Muftuoglu C, Mert U, Guldaval F, Asadi M, et al.
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762567
A comprehensive lipid profile was analyzed in patients with non-small cell lung cancer (NSCLC) using nanoflow ultrahigh-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. This study investigated 297 and 202 lipids in...
7.
Tetik Vardarli A, Ozgur S, Goksel T, Korba K, Karakus H, Asik A, et al.
Front Genet
. 2023 Jul;
14:1200262.
PMID: 37424727
Lung cancer (LC) is one of the most prevalent cancers with the highest fatality rate worldwide. Long noncoding RNAs (lncRNAs) are being considered potential new molecular targets for early diagnosis,...
8.
Scagliotti G, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al.
J Clin Oncol
. 2023 May;
41(14):2458-2466.
PMID: 37146426
Purpose: Cisplatin plus gemcitabine is a standard regimen for first-line treatment of advanced non-small-cell lung cancer (NSCLC). Phase II studies of pemetrexed plus platinum compounds have also shown activity in...
9.
Ghorbanizamani F, Moulahoum H, Celik E, Zihnioglu F, Beduk T, Goksel T, et al.
Biosensors (Basel)
. 2023 Mar;
13(3).
PMID: 36979612
Minimally invasive approaches for cancer diagnosis are an integral step in the quest to improve cancer survival. Liquid biopsies such as blood samples are matrices explored to extract valuable information...
10.
A drug-responsive multicellular human spheroid model to recapitulate drug-induced pulmonary fibrosis
Saygili E, Devamoglu U, Goker-Bagca B, Goksel O, Biray-Avci C, Goksel T, et al.
Biomed Mater
. 2022 May;
17(4).
PMID: 35617946
Associated with a high mortality rate, pulmonary fibrosis (PF) is the end stage of several interstitial lung diseases. Although many factors are linked to PF progression, initiation of the fibrotic...